Urology Oncology all Urologic Cancers (bladder, kidney, and prostate cancer), bladder/CA mass, renal mass/CA, prostate CA, elevated PSA, BPH, gross hematuria, abnormal prostate exam/cancer adrenal mass, pheochromocytoma, retroperitoneal mass and testicular mass.
Dr. Uchio is a nationally recognized leader in the management of GU malignancies. His expertise includes all areas of urologic oncology, including the advanced surgical treatment of prostate, renal, testis and bladder cancers. He utilizes laparoscopic, robotic and minimally invasive techniques (Cryo, RFA, HIFU), and newer technologies and therapies only available in clinical trials. Dr. Uchio performs the Artemis MRI targeted prostate biopsy system to diagnose and manage patients with prostate cancer. He is the Director of Clinical Research in the UC Irvine Health Department of Urology.
Prior to joining UC Irvine Health, Dr. Uchio was on faculty at Yale University School of Medicine specializing in urologic oncology, serving as the Chief of Urology and Director of Urologic Oncology/Robotics and Minimally Invasive Surgery at the VA Connecticut Healthcare System. He completed a fellowship in urologic oncology at the National Cancer Institute (NCI) in Bethesda, Md. in 2003.
Undergraduate: University of California, Irvine
Medical School: University of California, Irvine
Residency: University of Washington Medical Center
Fellowship Training: NIH Clinical Center / NCI